Skip to main content
S&P 5007,818.93+0.58%DOW51,521.28+0.49%NASDAQ27,599.89+0.45%BTC$85,520.00-0.35%ETH$2,697.04-0.63%GOLD$4,189.90+0.07%OIL$89.91+0.53%
Smart Investors Daily
SID Premium
RD

NASDAQ · RDNT

RadNet, Inc.

Healthcare · Medical - Diagnostics & Research

$70.28

Down-$0.29 (-0.41%)

Updated Oct 7, 2026, 8:00 AM

SID Score

5.3/10

Composite research score

Smart Money

58/100

Neutral

Market cap
6.07B
P/E ratio
-462.56
Dividend yield
0.00%
52-week range
$50.82 – $79.77
Volume
291.72K
Avg. volume
753.34K

Price performance · RDNT

RDNT price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 6, 2026

RDNT closed at $70.28 after 21 trading sessions, down 2.35% for the selected period.

Last close
$70.28
Period change
-2.35%
Period low
$67.70
Period high
$77.78
Daily close
View OHLC price history
RDNT OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 6, 2026$71.27$71.545$69.44$70.28291.72K
Oct 5, 2026$69.87$71.86$69.40$70.57681.37K
Oct 2, 2026$68.52$70.675$67.80$69.93574.2K
Oct 1, 2026$68.80$69.70$67.32$67.70928.74K
Sep 30, 2026$70.22$70.85$68.94$68.94621.24K
Sep 29, 2026$71.92$72.58$69.49$70.65501.04K
Sep 28, 2026$70.08$72.84$69.62$71.81528.18K
Sep 25, 2026$70.81$71.48$69.5849$70.79598.67K
Sep 24, 2026$73.11$73.70$70.96$71.31754.12K
Sep 23, 2026$73.61$74.345$72.68$73.21560.68K
Sep 22, 2026$73.71$74.805$73.01$73.93795.37K
Sep 21, 2026$76.27$76.4503$72.62$72.67796.17K
Sep 18, 2026$77.66$78.01$75.71$76.001.28M
Sep 17, 2026$76.44$78.005$75.80$77.78573.23K
Sep 16, 2026$77.12$78.9699$75.66$75.781.18M
Sep 15, 2026$75.63$79.77$75.345$77.121.59M
Sep 14, 2026$75.29$76.27$74.31$75.491.18M
Sep 11, 2026$75.34$75.9073$73.78$75.49610.33K
Sep 10, 2026$70.45$75.10$70.45$74.28801.88K
Sep 9, 2026$71.31$72.555$70.08$70.87575.14K
Sep 8, 2026$72.72$73.53$71.82$71.97455.28K

Latest RDNT news

The latest Smart Investors Daily articles mentioning RDNT.

Stock researchCompany · Overview

RDNT research

Overview

Company profile and research snapshot.

Company profile

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$88.00
Implied upside
—
Analysts
—
RDNT recent ratings
DateFirmRatingTarget
Aug 28, 2026BarclaysOverweight—
Aug 11, 2026Truist SecuritiesBuy—
May 20, 2026BarclaysOverweight—
Apr 21, 2026BarclaysOverweight—
Jan 9, 2026KeybancOverweight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 1, 2026

RadNet and WIN-NextGen™ Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals

New program introduces students and young adults to careers in radiology through mentorship, digital experiences and hands-on learning. OWINGS MILLS, Md., Oct. 01, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in high-quality, cost-effective outpatient diagnostic imaging and a global developer of digital health solutions, today announced a collaboration with WIN-NextGen, a leading workforce innovation network dedicated to cultivating talent across the 3S Workforce™ (STE

Yahoo · Sep 15, 2026

RadNet (RDNT) Stock May Be 23% Below Fair Value On Cash Flow

RadNet shares have put in a strong multi year run, and the real question now is whether the current US$75.49 price is still grounded in the cash the business can generate. With the stock no longer flying under the radar, the focus turns squarely to what its future cash flows are actually worth. Over the past 5 years RadNet has returned 174.0%, which puts a lot of accumulated optimism on the line when you ask whether those gains match the underlying cash flow profile. The business model leans...

Yahoo · Sep 9, 2026

RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026

LOS ANGELES, Sept. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026 at 07:45 a.m. Eastern Time. There will be simultaneous

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By